通过含有大麻素的PLGA纳米粒子增强代谢综合征管理:开发和体外评估
Mazen M El-Hammadi1, Lucía Martín-Navarro1, Esther Berrocoso2,3,4
1Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, Universidad de Sevilla, Sevilla, Spain.
Journal of biomedical materials research. Part A
|April 25, 2025
概括
聚合物纳米颗粒有效地提供大麻素 (CBD) 治疗代谢障碍. 这种新型纳米配方在体外改善了葡萄糖吸收和脂质概况,显示出对治疗代谢疾病的前景.
科学领域:
- 生物医学工程 生物医学工程
- 药理学 药理学是指药理学的学科.
- 代谢性疾病研究研究
背景情况:
- 代谢性疾病对健康构成重大挑战.
- 大麻素 (CBD) 显示出对代谢性疾病管理的潜力.
- 提高CBD的口服生物可用性和有效性至关重要.
研究的目的:
- 开发和评估包装CBD的聚乳-同-甘油酸 (PLGA) 纳米粒子 (NP).
- 在体外代谢综合征模型中评估CBD载荷NP的治疗疗效.
主要方法:
- 通过纳米沉,CBD被封装到PLGANP中.
- NP的特点是大小,封装效率和释放动力学.
- 在体外试验中,使用棕酸诱导的HepG2细胞来评估细胞活力,葡萄糖吸收,脂质积累和基因表达.
主要成果:
- 装有CBD的NP表现出高封装效率 (~100%) 和持续释放.
- CBD-NPs显著改善了葡萄糖的吸收,并减少了脂质积累,甘油三和胆固醇.
- 基因表达分析揭示了葡萄糖生成和脂肪酸氧化的调节途径.
结论:
- 含有CBD的PLGANP代表了代谢障碍治疗的有希望的策略.
- 纳米配方在体外增强了CBD的治疗效果.
- 需要进一步的体内研究来证实疗效.
相关概念视频
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...


